These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 29642934)

  • 61. APOBEC3B expression in breast cancer reflects cellular proliferation, while a deletion polymorphism is associated with immune activation.
    Cescon DW; Haibe-Kains B; Mak TW
    Proc Natl Acad Sci U S A; 2015 Mar; 112(9):2841-6. PubMed ID: 25730878
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Germline APOBEC3B deletion is associated with breast cancer risk in an Asian multi-ethnic cohort and with immune cell presentation.
    Wen WX; Soo JS; Kwan PY; Hong E; Khang TF; Mariapun S; Lee CS; Hasan SN; Rajadurai P; Yip CH; Mohd Taib NA; Teo SH
    Breast Cancer Res; 2016 May; 18(1):56. PubMed ID: 27233495
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Her2 amplification, Rel-A, and Bach1 can influence APOBEC3A expression in breast cancer cells.
    Dennis M; Hurley A; Bray N; Cordero C; Ilagan J; Mertz TM; Roberts SA
    PLoS Genet; 2024 May; 20(5):e1011293. PubMed ID: 38805570
    [TBL] [Abstract][Full Text] [Related]  

  • 64. An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers.
    Roberts SA; Lawrence MS; Klimczak LJ; Grimm SA; Fargo D; Stojanov P; Kiezun A; Kryukov GV; Carter SL; Saksena G; Harris S; Shah RR; Resnick MA; Getz G; Gordenin DA
    Nat Genet; 2013 Sep; 45(9):970-6. PubMed ID: 23852170
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The 29.5 kb APOBEC3B Deletion Polymorphism Is Not Associated with Clinical Outcome of Breast Cancer.
    Liu J; Sieuwerts AM; Look MP; van der Vlugt-Daane M; Meijer-van Gelder ME; Foekens JA; Hollestelle A; Martens JW
    PLoS One; 2016; 11(8):e0161731. PubMed ID: 27552096
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Functional Upregulation of the DNA Cytosine Deaminase APOBEC3B by Polyomaviruses.
    Verhalen B; Starrett GJ; Harris RS; Jiang M
    J Virol; 2016 Jul; 90(14):6379-6386. PubMed ID: 27147740
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Heat shock proteins stimulate APOBEC-3-mediated cytidine deamination in the hepatitis B virus.
    Chen Z; Eggerman TL; Bocharov AV; Baranova IN; Vishnyakova TG; Kurlander R; Patterson AP
    J Biol Chem; 2017 Aug; 292(32):13459-13479. PubMed ID: 28637869
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Multiregion whole-genome sequencing depicts intratumour heterogeneity and punctuated evolution in ovarian clear cell carcinoma.
    Yin X; Bi R; Ma P; Zhang S; Zhang Y; Sun Y; Zhang Y; Jing Y; Yu M; Wang W; Tan L; Di W; Zhuang G; Cai MC
    J Med Genet; 2020 Sep; 57(9):605-609. PubMed ID: 31862729
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Distinguishing preferences of human APOBEC3A and APOBEC3B for cytosines in hairpin loops, and reflection of these preferences in APOBEC-signature cancer genome mutations.
    Butt Y; Sakhtemani R; Mohamad-Ramshan R; Lawrence MS; Bhagwat AS
    Nat Commun; 2024 Mar; 15(1):2369. PubMed ID: 38499553
    [TBL] [Abstract][Full Text] [Related]  

  • 70. APOBEC3B reporter myeloma cell lines identify DNA damage response pathways leading to APOBEC3B expression.
    Yamazaki H; Shirakawa K; Matsumoto T; Kazuma Y; Matsui H; Horisawa Y; Stanford E; Sarca AD; Shirakawa R; Shindo K; Takaori-Kondo A
    PLoS One; 2020; 15(1):e0223463. PubMed ID: 31914134
    [TBL] [Abstract][Full Text] [Related]  

  • 71. APOBEC and ADAR deaminases may cause many single nucleotide polymorphisms curated in the OMIM database.
    Lindley RA; Hall NE
    Mutat Res; 2018 Jul; 810():33-38. PubMed ID: 29957488
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Differentiation signals induce
    Smith NJ; Reddin I; Policelli P; Oh S; Zainal N; Howes E; Jenkins B; Tracy I; Edmond M; Sharpe B; Amendra D; Zheng K; Egawa N; Doorbar J; Rao A; Mahadevan S; Carpenter MA; Harris RS; Ali S; Hanley C; Buisson R; King E; Thomas GJ; Fenton TR
    Res Sq; 2024 Mar; ():. PubMed ID: 38496447
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Genetic modifiers of APOBEC-induced mutagenesis.
    Mertz TM; Rice-Reynolds E; Nguyen L; Wood A; Bray N; Mitchell D; Lobachev K; Roberts SA
    bioRxiv; 2023 Apr; ():. PubMed ID: 37066362
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Cytidine deaminase Apobec3a induction in fallopian epithelium after exposure to follicular fluid.
    Brachova P; Alvarez NS; Van Voorhis BJ; Christenson LK
    Gynecol Oncol; 2017 Jun; 145(3):577-583. PubMed ID: 28215840
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Activation of DNA damage repair factors in HPV positive oropharyngeal cancers.
    Kono T; Hoover P; Poropatich K; Paunesku T; Mittal BB; Samant S; Laimins LA
    Virology; 2020 Aug; 547():27-34. PubMed ID: 32560902
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Involvement of APOBEC3B in mutation induction by irradiation.
    Saito Y; Miura H; Takahashi N; Kuwahara Y; Yamamoto Y; Fukumoto M; Yamamoto F
    J Radiat Res; 2020 Nov; 61(6):819-827. PubMed ID: 32880638
    [TBL] [Abstract][Full Text] [Related]  

  • 77. APOBEC mutagenesis and selection for NFE2L2 contribute to the origin of lung squamous-cell carcinoma.
    Cannataro VL; Kudalkar S; Dasari K; Gaffney SG; Lazowski HM; Jackson LK; Yildiz I; Das RK; Gould Rothberg BE; Anderson KS; Townsend JP
    Lung Cancer; 2022 Sep; 171():34-41. PubMed ID: 35872531
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Pan-cancer transcriptomic analysis dissects immune and proliferative functions of APOBEC3 cytidine deaminases.
    Ng JCF; Quist J; Grigoriadis A; Malim MH; Fraternali F
    Nucleic Acids Res; 2019 Feb; 47(3):1178-1194. PubMed ID: 30624727
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Analysis of APOBEC3A/3B germline deletion polymorphism in breast, cervical and oral cancers from South India and its impact on miRNA regulation.
    Revathidevi S; Manikandan M; Rao AK; Vinothkumar V; Arunkumar G; Rajkumar KS; Ramani R; Rajaraman R; Ajay C; Munirajan AK
    Tumour Biol; 2016 Sep; 37(9):11983-11990. PubMed ID: 27155849
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Transcriptional repression and apoptosis influence the effect of APOBEC3A/3B functional polymorphisms on biliary tract cancer risk.
    Liu W; Ji H; Zhao J; Song J; Zheng S; Chen L; Li P; Tan X; Ding Y; Pu R; Yin J; Han X; Cao G
    Int J Cancer; 2022 Jun; 150(11):1825-1837. PubMed ID: 35020946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.